Zacks Company Profile for Globus Medical, Inc. (GMED : NYSE) |
|
|
|
Company Description |
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Number of Employees: 5,300 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $57.80 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,332,862 shares |
Shares Outstanding: 135.38 (millions) |
Market Capitalization: $7,824.93 (millions) |
Beta: 1.19 |
52 Week High: $94.93 |
52 Week Low: $54.48 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-3.99% |
-7.58% |
12 Week |
-18.60% |
-31.53% |
Year To Date |
-30.12% |
-34.56% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Daniel T. Scavilla - President and Chief Executive Officer
David C. Paul - Executive Chairman and Director
Keith Pfeil - Chief Financial Officer and Chief Operating Office
David D. Davidar - Director
Robert Douglas - Director
|
|
Peer Information
Globus Medical, Inc. (ABMD)
Globus Medical, Inc. (DMDS)
Globus Medical, Inc. (CPWY.)
Globus Medical, Inc. (EQUR)
Globus Medical, Inc. (ECIA)
Globus Medical, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 379577208
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
|
|
Share - Related Items
Shares Outstanding: 135.38
Most Recent Split Date: (:1)
Beta: 1.19
Market Capitalization: $7,824.93 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.82 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $3.18 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: 10.78% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/05/25 |
|
|
|
|